GS0051: medical diagnostic and therapeutic preparations and devices for administering same, sold filled with diagnostic and therapeutic preparations or separately as a kit, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled or separately as a kit, the preparations including polynucleotides, proteins and/or organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms,; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g.; cancers which metastasized to the lung(s), breast, liver and prostate included
PM0000: EPI GENESIS PHARMACEUTICALS DOT COM
Case File Event Statements
9/7/2006 - 18 years ago
31 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
9/7/2006 - 18 years ago
30 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
12/29/2005 - 19 years ago
29 - EXTENSION 5 GRANTEDType:EX5G
12/29/2005 - 19 years ago
28 - EXTENSION 5 FILEDType:EXT5
12/29/2005 - 19 years ago
27 - TEAS EXTENSION RECEIVEDType:EEXT
7/1/2005 - 19 years ago
26 - EXTENSION 4 GRANTEDType:EX4G
7/1/2005 - 19 years ago
25 - EXTENSION 4 FILEDType:EXT4
7/1/2005 - 19 years ago
24 - TEAS EXTENSION RECEIVEDType:EEXT
1/10/2005 - 20 years ago
23 - EXTENSION 3 GRANTEDType:EX3G
12/23/2004 - 20 years ago
22 - EXTENSION 3 FILEDType:EXT3
12/23/2004 - 20 years ago
21 - TEAS EXTENSION RECEIVEDType:EEXT
7/28/2004 - 20 years ago
20 - EXTENSION 2 GRANTEDType:EX2G
6/30/2004 - 20 years ago
19 - EXTENSION 2 FILEDType:EXT2
7/16/2004 - 20 years ago
18 - PAPER RECEIVEDType:MAIL
7/19/2004 - 20 years ago
17 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
7/12/2004 - 20 years ago
16 - CASE FILE IN TICRSType:CFIT
6/30/2004 - 20 years ago
15 - TEAS EXTENSION RECEIVEDType:EEXT
1/22/2004 - 21 years ago
14 - EXTENSION 1 GRANTEDType:EX1G
12/31/2003 - 21 years ago
13 - EXTENSION 1 FILEDType:EXT1
12/31/2003 - 21 years ago
12 - TEAS EXTENSION RECEIVEDType:EEXT
7/1/2003 - 21 years ago
11 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
4/8/2003 - 21 years ago
10 - PUBLISHED FOR OPPOSITIONType:PUBO
3/19/2003 - 21 years ago
9 - NOTICE OF PUBLICATIONType:NPUB
1/29/2003 - 22 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
10/25/2002 - 22 years ago
7 - Sec. 1(B) CLAIM ADDEDType:1.BA
10/25/2002 - 22 years ago
6 - SEC. 1(A) CLAIM DELETEDType:1.AD
10/25/2002 - 22 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA